Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 335

Similar articles for PubMed (Select 17706161)

1.

Diagnosis and treatment of acute promyelocytic leukemia.

Jurcic JG, Soignet SL, Maslak AP.

Curr Oncol Rep. 2007 Sep;9(5):337-44. Review.

PMID:
17706161
2.

[Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].

Chen SJ, Chen LJ, Zhou GB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):1-8. Chinese.

PMID:
15748426
3.

Acute promyelocytic leukemia in childhood.

Gregory J, Feusner J.

Curr Oncol Rep. 2009 Nov;11(6):439-45. Review.

PMID:
19840521
4.

Monitoring PML-RARalpha in acute promyelocytic leukemia.

Jurcic JG.

Curr Oncol Rep. 2003 Sep;5(5):391-8. Review.

PMID:
12895391
5.

The expanding role of arsenic in acute promyelocytic leukemia.

Tallman MS.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S25-9. doi: 10.1053/j.seminhematol.2008.07.008. Review.

PMID:
18760708
6.

Acute promyelocytic leukemia: from highly fatal to highly curable.

Wang ZY, Chen Z.

Blood. 2008 Mar 1;111(5):2505-15. doi: 10.1182/blood-2007-07-102798. Review.

7.

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease.

Mistry AR, Pedersen EW, Solomon E, Grimwade D.

Blood Rev. 2003 Jun;17(2):71-97. Review.

PMID:
12642121
8.

Acute promyelocytic leukemia: recent advances in diagnosis and management.

Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA.

Semin Oncol. 2008 Aug;35(4):401-9. doi: 10.1053/j.seminoncol.2008.04.010.

PMID:
18692690
10.

Acute promyelocytic leukemia. New methods in diagnosis and treatment.

Varghese L, Janckila A, Yam LT.

J Ky Med Assoc. 1999 Feb;97(2):61-5. Review.

PMID:
10073058
11.

Advances in the treatment of relapsed acute promyelocytic leukemia.

Douer D.

Acta Haematol. 2002;107(1):1-17. Review.

PMID:
11818666
12.

The design of selective and non-selective combination therapy for acute promyelocytic leukemia.

Jing Y, Waxman S.

Curr Top Microbiol Immunol. 2007;313:245-69. Review.

PMID:
17217047
13.

Acute promyelocytic leukemia: biology and treatment.

Fenaux P, Chomienne C, Degos L.

Semin Oncol. 1997 Feb;24(1):92-102. Review.

PMID:
9045308
14.
15.
16.

In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligos.

Caprodossi S, Galluzzi L, Biagetti S, Della Chiara G, Pelicci PG, Magnani M, Fanelli M.

Oncol Res. 2005;16(3):157-66.

PMID:
16925116
17.

Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.

Sirulnik LA, Stone RM.

Clin Adv Hematol Oncol. 2005 May;3(5):391-7, 429. Review.

PMID:
16167012
18.

[Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia].

Liu ZL, Luo JM, Wang FX, Zhang XJ, Du XY, Yao L, Dong ZR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Dec;11(6):587-90. Chinese.

PMID:
14706140
19.

Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.

Zheng X, Seshire A, RĂ¼ster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.

Haematologica. 2007 Mar;92(3):323-31.

20.

All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.

Quezada G, Kopp L, Estey E, Wells RJ.

Pediatr Blood Cancer. 2008 Jul;51(1):133-5. doi: 10.1002/pbc.21529.

PMID:
18293388
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk